Home › Ovarian Cancer › NCT05752448

Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)

POSTCARE-O: Survivorship Care for Women Living With Ovarian Cancer

Who can join

Ages 18 and older · Women

Inclusion Criteria:

* Stage 2-4 ovarian cancer
* Treated with some combination of surgery, chemotherapy, biologics, maintenance therapy
* Within 6 months of completion of initial treatment (continued maintenance therapy okay)
* Able to provide consent in English or Spanish

Exclusion Criteria:

* Admission to hospice at the completion of treatment for ovary cancer

About the study

This study will enroll 120 women living with ovarian cancer following completion of initial treatment. Our objective is to test an intervention designed to provide support during the survivorship transition for this population, who live with a high degree of morbidity related to the illness and its treatment as well as a high risk of recurrence. Study participants will be randomly assigned to receive survivorship care using the POSTCare-O process or usual care. The primary outcome is quality of life at 12 weeks after intervention.

What is being tested

• POSTCare Survivorship transition process (behavioral)

Sponsor: Baylor College of Medicine · Participants: 120 · Started: Oct 1, 2023

Contact the study team

• Nimrah Saleem, MPH · Phone: 713-798-2272
• Judy Bettencourt, MPH · Phone: (713) 500-9527

Official record on ClinicalTrials.gov — NCT05752448

Locations in the U.S.

Conditions

• Ovarian Cancer
• Depression

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.